InsidersTradesSigma
Follow the 셀루메드 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀루메드 has logged 1 insider filings. Market capitalisation: €83.9bn. The latest transaction was reported on 19 March 2026 (Sale). Among the most active insiders: 인스코비. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
셀루메드 活跃于医疗保健和制药领域，在 XKRX 市场上市。该公司专注于为医疗领域开发创新解决方案。